Global Chondroitin Sulfate Market Outlook 2018-2023

The global chondroitin sulfate market is expected to attain a higher position during the estimated period. Osteoarthritis (OA) is a chronic joint disease characterized by rise in loss of cartilage and increasing inflammation of synovial membrane. Besides, the regular OA therapy/ies is/are led by non steroidal anti-inflammatory drugs. The treatment with chondroitin sulfate accompanies usage of glucosamine, collagen hydrolysate and hyaluronic acid. 

Using chondroitin sulfate, chondro protective action takes place, which is anti-inflammatory by nature and stimulates the anabolic process of the cartilage. Chondroitin sulfate market is driven by rise in use of chondroitin sulfate by osteoarthritis patients. Osteoarthritis is one of the major forms of disease affecting older population. Increase in geriatric population is another reason for market developments. Additionally, rise in cataract patients that demand chondroitin sulfate is likely to supplement the market demand. 

Application segment for chondroitin sulfate market is segmented as dietary supplement, pharmaceutical, veterinary and cosmetics.Dietary supplements account for a significant market share owing to rise in use for osteoarthritis. By source, the market is bifurcated into porcine and bovine. Bovine segment accounted for a significant market share due to rising preference.

Geographical segmentation for chondroitin sulfate market spans North America, South America, Europe, Asia-Pacific, Middle East and Africa. North American and European markets are likely to lead the market growth due to presence of regulatory bodies and demand for quality medical treatment. Presence of medical infrastructure and availability of patients is likely to propel the market growth. Asia-Pacific regions are likely to witness a higher position owing to medical developments in emerging economies and geriatric population with chronic ailments.

The key players profiled in the chondroitin sulfate market report are TSI Group Ltd, SandongRunxin Biotechnology Co Ltd, Qingdao WanTuMing Biological Products Co Ltd, Pacific Rainbow International Inc, Summit Nutritionals International Inc, Yantai RuikangdaBiochemical Products Co Ltd, Bioiberica, S.A.U., Seikagaku Corporation, JiaxingHengjie and Biopharmaceutical Co Ltd.

The Global Market for chondroitin sulfate to 2023 offers detailed coverage of chondroitin sulfate industry and presents main market trends. The market research gives historical and forecast market size, demand and production forecasts, end-use demand details, price trends, and company shares of the leading chondroitin sulfate producers to provide exhaustive coverage of the chondroitin sulfate.

Report contents include
- Analysis of the chondroitin sulfate market including revenues, future growth, market outlook
- Historical data and forecast
- Regional analysis including growth estimates
- Analyzes the end user markets including growth estimates.
- Profiles on chondroitin sulfate including products, sales/revenues, and market position
- Market structure, market drivers and restraints.

Key regions
- North America
- Europe
- Asia Pacific
- Middle East and Africa
- South America

Key Vendors
- request free sample to get a complete list of companies